IGXT — IntelGenx Technologies Balance Sheet
0.000.00%
HealthcareAdventurousMicro Cap
- $30.51m
- $51.49m
- $1.04m
Annual balance sheet for IntelGenx Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.91 | 2.24 | 9.95 | 2.53 | 2.28 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.756 | 1.25 | 1.12 | 0.868 | 0.79 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3.22 | 4.3 | 11.4 | 3.79 | 3.44 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.05 | 6.56 | 6.22 | 5.16 | 4.59 |
| Other Long Term Assets | |||||
| Total Assets | 11 | 11.1 | 17.9 | 9.19 | 8.28 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.45 | 4.37 | 7.02 | 2.37 | 8.42 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.7 | 12.1 | 14 | 12.6 | 20.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.293 | -0.953 | 3.87 | -3.42 | -12.2 |
| Total Liabilities & Shareholders' Equity | 11 | 11.1 | 17.9 | 9.19 | 8.28 |
| Total Common Shares Outstanding |